Literature DB >> 26501143

Docetaxel Induced Sclerosing Cholangitis.

Jennifer L Horsley-Silva, Elizabeth N Dow, Christine O Menias, Maxwell L Smith, Estrella M Carballido, Keith D Lindor, Hugo E Vargas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26501143     DOI： 10.1007/s10620-015-3914-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

Review 1.  Transporters and drug therapy: implications for drug disposition and disease.

Authors:  Richard H Ho; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2005-09       Impact factor: 6.875

2.  Severe docetaxel overdose induced by pharmacokinetic interaction with dronedarone.

Authors:  Dominique Vodovar; Nicolas Mongardon; Laurence Moachon; Michel Arnaout; Philippe Beuzeboc; François Lokiec; Keyvan Rezai; Frédéric Pène
Journal:  J Clin Oncol       Date:  2011-07-05       Impact factor: 44.544

3.  The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance.

Authors:  J Hirth; P B Watkins; M Strawderman; A Schott; R Bruno; L H Baker
Journal:  Clin Cancer Res       Date:  2000-04       Impact factor: 12.531

Review 4.  Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management.

Authors:  Mohamad H Imam; Jayant A Talwalkar; Keith D Lindor
Journal:  Clin Liver Dis       Date:  2012-12-20       Impact factor: 6.126

5.  Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

Authors:  R Bruno; D Hille; A Riva; N Vivier; W W ten Bokkel Huinnink; A T van Oosterom; S B Kaye; J Verweij; F V Fossella; V Valero; J R Rigas; A D Seidman; B Chevallier; P Fumoleau; H A Burris; P M Ravdin; L B Sheiner
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Metastatic prostate cancer simulating sclerosing cholangitis.

Authors:  J Taylor; K Lindor
Journal:  J Clin Gastroenterol       Date:  1993-03       Impact factor: 3.062

Review 7.  The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

Authors:  Thorir D Bjornsson; John T Callaghan; Heidi J Einolf; Volker Fischer; Lawrence Gan; Scott Grimm; John Kao; S Peter King; Gerald Miwa; Lan Ni; Gondi Kumar; James McLeod; Scott R Obach; Stanley Roberts; Amy Roe; Anita Shah; Fred Snikeris; John T Sullivan; Donald Tweedie; Jose M Vega; John Walsh; Steven A Wrighton
Journal:  J Clin Pharmacol       Date:  2003-05       Impact factor: 3.126

8.  Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.

Authors:  P Wils; V Phung-Ba; A Warnery; D Lechardeur; S Raeissi; I J Hidalgo; D Scherman
Journal:  Biochem Pharmacol       Date:  1994-10-07       Impact factor: 5.858
  8 in total
  7 in total

1.  Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines.

Authors:  Harshad Devarbhavi; Guruprasad Aithal; Sombat Treeprasertsuk; Hajime Takikawa; Yimin Mao; Saggere M Shasthry; Saeed Hamid; Soek Siam Tan; Cyriac Abby Philips; Jacob George; Wasim Jafri; Shiv K Sarin
Journal:  Hepatol Int       Date:  2021-02-27       Impact factor: 6.047

2.  Bile Duct Injury due to Drug Induced Liver Injury.

Authors:  Priya Grewal; Jawad Ahmad
Journal:  Curr Hepatol Rep       Date:  2019-07-15

3.  Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management.

Authors:  Borui Pi; Jin Wang; Yifan Tong; Qiao Yang; Fangfang Lv; Yunsong Yu
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

4.  Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury.

Authors:  Jawad Ahmad; Simona Rossi; Shuchi K Rodgers; Marwan Ghabril; Robert J Fontana; Andrew Stolz; Paul H Hayashi; Huiman Barnhart; David E Kleiner; Einar S Bjornsson
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-30       Impact factor: 11.382

Review 5.  Drug-induced cholestasis.

Authors:  Vinay Sundaram; Einar S Björnsson
Journal:  Hepatol Commun       Date:  2017-09-11

6.  Long-Term Outcomes After Drug-Induced Liver Injury.

Authors:  Paul H Hayashi; Einar S Bjornsson
Journal:  Curr Hepatol Rep       Date:  2018-07-02

7.  Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient.

Authors:  Zhuo Zhang; Ling Xu; Naishan Qin; Jixin Zhang; Qian Xiang; Qian Liu; Yuanjia Cheng; Yuge Bai; Qianxin Liu; Yinhua Liu; Xuening Duan; Yimin Cui
Journal:  Thorac Cancer       Date:  2021-05-06       Impact factor: 3.500
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.